EIF4A2 and acute myeloid leukemia: Importantly, both RBM17 and EIF4A2 knockdown inhibited protein synthesis and downregulated at the protein level, the expression of factors enriched in the ribosome biogenesis pathway, suggesting a link between elevated expression of RBM17 along with its downstream target EIF4A2 and protein synthesis activation in primitive AML cells.